<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Cannabinoids have neuroprotective potentials, and the expression of endocannabinoids as well as cannabinoid receptors is induced after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>They also induce <z:hpo ids='HP_0002045'>hypothermia</z:hpo> by lowering the hypothalamic set point </plain></SENT>
<SENT sid="2" pm="."><plain>We have estimated the significance of such <z:hpo ids='HP_0002045'>hypothermia</z:hpo> in ischemic neuroprotection following systemic administration of WIN 55,212-2, a synthetic cannabinoid receptor <z:chebi fb="4" ids="48705">agonist</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>Results showed that WIN 55,212-2 significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes of rats subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp>) and significantly decreased ischemic CA1 damage in rats subjected to global <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> (two-vessel occlusion) </plain></SENT>
<SENT sid="4" pm="."><plain>A significant (approximately 50%) part of this neuroprotection was provided by WIN 55,212-2 induced <z:hpo ids='HP_0002045'>hypothermia</z:hpo> (33.7+/-1.1 degrees C/34.9+/-1.6 degrees C), because prevention of <z:hpo ids='HP_0002045'>hypothermia</z:hpo> by maintaining body core temperatures between 37.0 and 38.0 degrees C dissolved the neuroprotective effect into a hypothermic component and an unidentified component </plain></SENT>
<SENT sid="5" pm="."><plain>Finally, the ability of WIN 55,212-2 to reduce levels of the proinflammatory cytokine IFNgamma in the infarcted hemisphere of rats subjected to focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> required <z:hpo ids='HP_0002045'>hypothermia</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>For the cannabinoid WIN 55,212-2, we have isolated and directly demonstrated that <z:hpo ids='HP_0002045'>hypothermia</z:hpo> is only part of, although significant, cannabinoid mediated neuroprotection in both global and focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>We conclude that cannabinoids are reliable candidates for drug-induced <z:hpo ids='HP_0002045'>hypothermia</z:hpo> and neuroprotection </plain></SENT>
<SENT sid="8" pm="."><plain>These neuroprotective effects of cannabinoids could provide the basis for potential therapeutic uses of cannabinoids and/or endocannabinoids in <z:hpo ids='HP_0001297'>stroke</z:hpo> </plain></SENT>
</text></document>